American College Of Surgeons - Inspiring Quality: Highest Standards, Better Outcomes

ACS Clinical Research Program Committees

The American College of Surgeons Clinical Research Program (ACS CRP) maintains one administrative committee (Education) and three scientific committees (Cancer Care Delivery Research, Cancer Care Standards Development, and Dissemination & Implementation).

Education Committee

Goals

  • Increase knowledge and awareness of ongoing clinical trials
  • Increase knowledge and awareness of new evidence (clinical trial results) and practice standards
  • Reduce the time from trials reporting to practice implementation

ACS CRP Articles from the Bulletin of the American College of Surgeons 2019

December 2019: ALCHEMIST trial has potential to improve outcomes after lung cancer resection

November 2019: Could axillary reverse mapping be useful in reducing surgical comorbidities?

October 2019: Evolution in the management of desmoid tumors: Challenging the role of upfront surgical resection

September 2019: Putting the needle before the knife: Minimally invasive approaches to diagnostic lymph node biopsy in melanoma

August 2019: Gastric cancer: Recent updates in surgical and multimodality therapy

July 2019: Organ preservation in rectal adenocarcinoma: The OPRA Trial

June 2019: Opportunities at Clinical Congress 2019 to increase surgeon participation in clinical research

May 2019: Defining the optimal treatment of locally advanced gastric cancer

April 2019: Preoperative smoking intervention techniques improve outcomes for lung cancer patients

March 2019: Atezolizumab in the adjuvant treatment of stage III colon cancer: Can PD-L1 inhibition improve survival?

February 2019: Cytoreduction with or without HIPEC: Where do we go from here?

January 2019: Robotic surgery for hepatic neoplasms: Where does it fit in the minimally invasive surgery landscape?

ACS CRP Honorary Lecturers at the Alliance for Clinical Trials in Oncology Group Meetings

Ronald P. DeMatteo, MD, FACS: Rapid adoption of tyrosine kinase inhibitors in GIST through clinical trials (Alliance Group Meeting November 2019)

Lawrence Shulman, MD, FACP: Phase III Randomized Clinical Trials, Pragmatic Trials, and Big Data: What is the future? (Alliance Group Meeting November 2018)

Kelly Hunt, MD, FACS: How co-operative group clinical trials have shaped the surgical management of breast cancer (Alliance Group Meeting November 2016)

Heidi Nelson, MD, FACS: The future of surgical research within the changing landscape of research funding (Alliance Group Meeting November 2015)

Clifford Ko MD, MS, MSHS, FACS: Surgical quality management and outcomes in oncologic care (Alliance Group Meeting May 2015)

Elaine Mardis, PhD: Information from genomic analysis from Z1031 and beyond (Alliance Group Meeting November 2014)

Dissemination & Implementation Committee

Goals

  • Develop strategies for disseminating key cancer clinical trial results as well as design implementation research programs for cancer guidelines
  • Collaborate with the Commission on Cancer and components of the ACoS and the Alliance to disseminate and implement standards based on new information from clinical trials
  • Investigate novel ways to hasten and broaden uptake in clinical practice of changes indicated by results of clinical trials

Cancer Care Standards Development Committee

Goals

  • Promote prompt dissemination and adoption of clinical trials results by all practitioners involved in cancer care
  • Provide a focus for research to determine the impact of clinical decision support tools on cancer treatment outcomes
  • Ensure optimal research quality by review of the surgical components of Alliance protocols

Cancer Care Delivery Research Committee

Goal

Improve cancer care outcomes through high-quality health services that leverage the multidisciplinary collaboration and research infrastructure of the Alliance for clinical Trials in Oncology, NCI Community Oncology Research Program (NCORP), and other partners to generate new knowledge and facilitate the implementation and dissemination of research findings throughout the oncology community.

Active NCORP CCDR Protocols

A191402CD: Testing decision aids to improve prostate cancer decisions for minority men
PI: Jon Tilburt, MD, MPH

A231601CD: Improving surgical care and outcomes in older cancer patients through implementation of an efficient pre-surgical toolkit (OPTI-Surg)
PIs: George Chang, MD, MS; Emily Finlayson, MD, MS

A231602CD: Assessing financial toxicity in patients with blood cancers
PI: Rena Conti, PhD

A231701CD: Increasing socioeconomically disadvantaged patients’ engagement in breast cancer surgery decision making through a shared decision making intervention
PI: Heather Neuman, MD

Alliance Foundation Trials (AFT) CCDR Protocols

AFT 25: Comparison of operative to monitoring and endocrine therapy for low risk DCIS: The COMET trial
PI: Shelley Hwang, MD, MPH

AFT 28: CANVAS randomized trial comparing direct oral anticoagulants to low molecular weigh heparin +/- warfarin for VTE in cancer
PI: Deborah Schrag, MD, MPH

AFT 39: Electronic patient reporting of symptoms during outpatient cancer treatment: A U.S. national randomized controlled trial (PRO-TECT)
PI: Ethan Basch, MD, MSc

Contact Us

For more information on the ACS CRP committees or to inquire about participation, please e-mail clinicalresearchprogram@facs.org.